The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Conditions: Progressive Supranuclear Palsy; Multiple System Atrophy; Corticobasal Syndrome Interventions: Dietary Supplement: Nicotinamide Riboside; Other: Placebo Sponsors: Haukeland University Hospital; Oslo universitetssykehus HF; Akershus Universitetssykehus HF; Vestre Viken HF; Sykehuset Østfold HF; Nevro Arendal AS; Helse Førde HF; Helse Fonna HF; Universitetssykehuset Nord Norge HF; Helse Møre og Romsdal HF; Nordlandssykehuset HF Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials